SCHEMBL7124716

SCHEMBL7124716

COc1ccc2oc(-c3ccc(O)cc3)c(O)c(=O)c2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 2/20 0.74
CSNK2B P67870 2/20 0.74
CSNK2A1 P68400 2/20 0.74
MAPT P10636 9/20 0.72
CYP3A4 P08684 8/20 0.72
KDM4E B2RXH2 8/20 0.72
HSD17B10 Q99714 6/20 0.72
MEN1 O00255 6/20 0.72
KMT2A Q03164 6/20 0.72
CYP2C9 P11712 5/20 0.72
ALDH1A1 P00352 7/20 0.71
HPGD P15428 7/20 0.71
TP53 P04637 6/20 0.71
CASP1 P29466 2/20 0.71
CASP7 P55210 2/20 0.71
MAOA P21397 2/20 0.64
SMN1; SMN2 Q16637 3/20 0.62
ACHE P22303 2/20 0.62
BACE1 P56817 2/20 0.62
MAPK1 P28482 4/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4650608 0.94 CSNK2A2 (0.82) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL15676583 0.89 KDM4E (0.74) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL2121813 0.89 KDM4E (0.74) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL30266769 0.89 CYP3A4 (0.90) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL7659274 0.87 ADORA3 (0.81) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL7606772 0.86 CSNK2A2 (0.67) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL4648874 0.86 ABCG2 (0.82) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL5138118 0.85 MAPT (0.84) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL4648920 0.85 CSNK2A2 (1.00) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4
SCHEMBL31356554 0.85 CSNK2A2 (1.00) CSNK2A2CSNK2BCSNK2A1MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003504327-A 2003-02-04 JP claimed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP claimed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO claimed
US-6555523-B1 Such as 3',4'-diacetoxy-5,6,7-trimethoxyflavone or naringin in the treatment HIV, picornavirus, and/or respiratory virus CASCADE ESTATES LTD. (MU) 2003-04-29 US disclosed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP disclosed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO disclosed